PROGRAM CHAIR
Stephen Salloway, M.D., M.S.
Professor, Psychiatry and Human Behavior
Professor of Neurology, Alpert Medical School of Brown University
Associate Director of the Brown Center for Alzheimer’s Research
Providence, RI
PROGRAM DESCRIPTION
The planned innovative series intends to help healthcare providers improve their understanding of the burden of early Alzheimer’s disease on patients and caregivers; highlight the value of collaborating with a multidisciplinary team to determine the best practices for diagnosis of early Alzheimer’s disease; review new and ongoing clinical trials on disease-modifying therapy of early Alzheimer’s disease. This program will also outline the maintenance dosing of disease-modifying treatment and assess the risk of imaging abnormalities associated with the management of Alzheimer’s disease with anti-amyloid therapy.
TARGET AUDIENCE
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including Alzheimer’s disease specialists, neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.
LEARNING OBJECTIVES
- Describe the burden of early Alzheimer’s disease on patients and caregivers
- Evaluate best practices in the diagnosis of early Alzheimer’s disease through multidisciplinary specialty collaboration
- Summarize current clinical data informing the use of disease-modifying therapy in the management of early Alzheimer’s disease
- Discuss the potential need for continued and maintenance dosing of disease-modifying therapies in early Alzheimer’s disease
- Assess the risk of ARIA in the management of Alzheimer’s disease with anti-amyloid therapy
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtual activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Stephen Salloway, M.D., M.S. | Consulting Fee | Biogen, Eisai, Lilly, Novartis, Genentech, NovoNordisk, Prothena, AbbVie, Kisbee, Acumen, CognitionRX and Roche. |
| Contracted Research | Biogen, Eisai, Genentech, Roche, Novartis, Lilly |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Mike Milano, MD, Has received royalties from Wolters Kluwer (Up ToDate author royalties).
- Shilpa Lalchandani, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa A. Johnson, Program Director for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]
RELEASED DATE: November 22, 2024
EXPIRATION DATE: November 22, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
